BLUESTEIN R H & CO LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 149 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
BLUESTEIN R H & CO LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2017$76,000
+18.8%
12,0000.0%0.01%
+25.0%
Q4 2016$64,000
-5.9%
12,0000.0%0.00%0.0%
Q3 2016$68,000
+3.0%
12,0000.0%0.00%
-20.0%
Q2 2016$66,000
-17.5%
12,000
+11.0%
0.01%
-16.7%
Q1 2016$80,000
-11.1%
10,8110.0%0.01%0.0%
Q4 2015$90,000
-7.2%
10,8110.0%0.01%
-14.3%
Q3 2015$97,000
-25.4%
10,8110.0%0.01%
-12.5%
Q2 2015$130,000
+20.4%
10,811
+8.1%
0.01%
+14.3%
Q1 2015$108,00010,0000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2016
NameSharesValueWeighting ↓
MSD Partners, L.P. 15,151,516$49,697,00012.67%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 9,642,760$31,628,0005.74%
MILLER VALUE PARTNERS, LLC 12,619,730$41,393,0001.84%
MAGNOLIA CAPITAL ADVISORS LLC 90,585$297,0000.38%
Sargent Investment Group, LLC 232,025$759,0000.28%
Old West Investment Management, LLC 210,583$690,0000.20%
Virtus ETF Advisers LLC 112,619$369,0000.18%
tru Independence LLC 213,712$701,0000.10%
AIGEN INVESTMENT MANAGEMENT, LP 180,297$591,0000.08%
Golden State Wealth Management, LLC 90,585$297,0000.08%
View complete list of ZIOPHARM ONCOLOGY INC shareholders